“Longevity is not just a trend, it is a paradigm shift,” says Burcu Andreae-Nehlsen, President Derma & Health Care at Beiersdorf , the company which owns beauty brands Eucerin, Nivea and La Praire. The German beauty giant is at the forefront of the longevity conversation with 15 years of research in epigenetics already under its belt. Epigenetics – considered by many to be a major piece of the longevity puzzle – identifies a link between environmental factors, such as diet, pollution, sun, stress and gene expression. Covering topics from cellular mechanisms of ageing to validated claims and clinical testing, the Anti-Ageing Skin Care Conference offers a rare opportunity to hear the latest research directly from the experts generating it. Find out more HERE . Chemical markers that attach to our DNA have been found to “switch” genes on and off, without changing the genetic material itself. After more than a decade of research and scanning more than 50,000 different active ingredients, Beiersdorf found Epicelline, an active ingredient which “reactivates” genes connected to youth, essentially reversing the biological clock. Bringing Beiersdorf’s epigenetic breakthrough to market This breakthrough ingredient debuted under Beierdorf’s dermatological brand Eucerin in September 2024, with Eucerin Hyaluron-Filler Epigenetic Serum. Nivea followed in September 2025 with Cellular Epigenetics Age Rewind Face Serum with Epicelline. Longevity is an area where you can bridge the short-term results with the long-term results – prevention and correction Beiersdorf's bet on longevity comes amid a major shift in the beauty industry . As our understanding of the underlying mechanisms which contribute to ageing is being revolutionised, so is consumer knowledge. Eucerin’s epigenetic innovation is an “anti-ageing” serum, but Andreae-Nehlsen – who joined Beiersdorf from L’Oréal in late 2025 and leads its dermatological skin care portfolio and plaster brands with responsibility for Eucerin, Aquaphor , Hansaplast, Curitas, and Elastoplast – is well aware of the changing conversation around the term as the longevity shift takes hold. “It is a very complex and new topic. It is a new area of science, and we are also assessing different semantic angles so far within our portfolio,” she says. Not yet a Subscriber ? This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Cosmetics Business. Subscribe now Already a subscriber? Sign in here. Share on LinkedIn Share on Facebook See more Not yet a Subscriber ? This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Cosmetics Business. Share on LinkedIn Share on Facebook

You may also like Beiersdorf CEO warns EU cosmetics industry could become ‘overburdened’ with impending regulations Trending Articles L’Oréal and Cosmax pen agreement to collaborate on next-generation beauty products The agreement will combine L’Oréal’s beauty science and consumer insights with manufacturer Cosmax’s K-beauty-inspired product design expertise to develop next-generation beauty innovations Estée Lauder Companies on helping acquired ‘indie’ brands thrive as The Ordinary nears $1 billion sales Estée Lauder Companies’ CEO Stéphane de la Faverie has discussed how a new model under the beauty giant’s ‘Beauty Reimagined’ turnaround efforts has helped fuel the growth of brands such as The Ordinary and Kilian Paris Perfumer Francis Kurkdjian restores 13 iconic Dior fragrances for Dioriginals collection French luxury fashion house Dior and its Perfume Creation Director Francis Kurkdjian have been inspired by nearly 80 years of fragrance archives to restore iconic Dior scents, such Diorama, Diorissimo and Dioressence The Ordinary opens ‘playful’ PDRN pop-up highlighting viral ingredient in first-ever eye cream Visitors to The Ordinary’s immersive experience in London, UK, will learn about the vegan biotech-derived PDRN used in the Estée Lauder Companies-owned skin care brand’s new Lacto-PDRN 4% + B9 Eye Cream You need to be a subscriber to read this article. Click here to find out more. Byoma aims to ‘democratise’ longevity beauty category with £25 serum Byoma has entered longevity beauty with Longevit-8 Peptide Serum – formulated with a patented GHK-Cu Longevity Matrix, vegan Phyto-PDRN + NMN, and the brand’s signature Tri-Ceramide Complex to boost skin prejuventation – stating the category should not be about ‘premium price points’ London Packaging Week 2026 You may also like Beiersdorf CEO warns EU cosmetics industry could become ‘overburdened’ with impending regulations Beiersdorf unveils Eucerin acne-prone skin treatment based on 20 years of microbiome research Nivea extends longevity offering with epigenetics eye serum featuring cryogenic technology Beiersdorf cuts sales guidance as Nivea turnaround ‘remains too isolated’ L'Oréal CEO speaks out on impact of Middle East conflict on the business Beiersdorf faces challenging start to the year as Nivea and La Prairie sales fall Beiersdorf ramps up innovation with €100 million skin care venture capital fund